References
- Jensen EA, Demauro SB, Kornhauser M, Aghai ZH, Greenspan JS, Dysart
KC. Effects of multiple ventilation courses and duration of mechanical
ventilation on respiratory outcomes in extremely low-birth-weight
infants. JAMA Pediatr . 2015; 169 : 1011-1017.
- Gizzi CC, Moretti C, Agostino R. Weaning from mechanical ventilation.J. Matern. Fetal. Neonatal. Med. 2011; 24 : 61-63.
- Gupta S, Prasanth K, Chen CM, Yeh TF. Postnatal corticosteroids for
prevention and treatment of chronic lung disease in the preterm
newborn. Int. J. Pediatr . 2012; 2012 : p. 315642.
- Kamlin COF, Davis PG, Morley CJ. Predicting successful extubation of
very low birthweight infants. Arch. Dis. Child. Fetal. Neonatal.
Ed . 2006; 91 : 180-183.
- Ng PC. The effectiveness and side effects of dexamethasone in preterm
infants with bronchopulmonary dysplasia. Arch. Dis. Child.1993; 68 : 330-336.
- Cheong JLY, Doyle LW. Long-term effects of postnatal corticosteroids
to prevent or treat bronchopulmonary dysplasia : Balancing the risks
and benefits. Semin. Fetal. Neonatal. Med . 2019; 24:197-201
- Cuna A,Govindarajan S, Oschman A, Dai H, Brophy K, Norberg M, Truong
W. A comparison of 7-day versus 10-day course of low-dose
dexamethasone for chronically ventilated preterm infants. J.
Perinatol . 2017; 37 : 301-305.
- Doyle LW, Ehrenkranz RA, Halliday HL. Postnatal hydrocortisone for
preventing or treating bronchopulmonary dysplasia in preterm infants:
a systematic review. Neonatology. 2010; 98 : 111-117.
- Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Late (>
7 days) systemic postnatal corticosteroids for prevention of
bronchopulmonary dysplasia in preterm infants. Cochrane Database
Syst. Rev . 2017; 10 : CD001145
- Halliday HL, Ehrenkranz RA, Doyle LW. Late (>7 days)
postnatal corticosteroids for chronic lung disease in preterm infants.Cochrane Database Syst. Rev. 2009; 1 : CD001145
- Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH. Outcomes
at school age after postnatal dexamethasone therapy for lung disease
of prematurity. N. Engl. J. Med. 2004; 350 : 1304-1313.
- Doyle LW, Cheong JLY. Postnatal corticosteroids to prevent or treat
bronchopulmonary dysplasia- Who might benefit? Semin. Fetal.
Neonatal. Med . 2017; 22 : 290-295
- Grier DG, Halliday HL. Corticosteroids in the prevention and
management of bronchopulmonary dysplasia. Semin. Neonatol .
2003; 8 : 83-91.
- Doyle LW, Ehrenkranz RA, Halliday HL, Davis PG, Sinclair JC. An update
on the impact of postnatal systemic corticosteroids on mortality and
cerebral palsy in preterm infants: Effect modification by risk of
bronchopulmonary dysplasia. J. Pediatr. 2014; 165 :
1258-1260
- Kim HR, Kim JY, Yun B, Lee B, Choi CW, Kim BL. Interstitial pnuemonia
pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia
in preterm infants. BMC. Pediatr . 2017; 17 :125.
- Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR, A simulation
study of the number of events per variable in logistic regression
analysis. Journal of Clinical Epidemiology . 1996; 49 (12):
1373–1379.
- Cuna A, Lewis T, Dai H, Nyp M, Truog W. Timing of postnatal
corticosteriod treatment for bronchopulmonary dysplasia and its effect
on outcomes. Pediatric. Pulmonol . 2019; 54: 165-170